15 Five years of exemestane as initial therapy compared to tamoxifen followed by exemestane for a total of 5 years: the TEAM trial, a prospective, randomized, phase III trial in postmenopausal women with hormone receptor-positive early breast cancer
A. Hasenburg, C.J.H. van de Velde, C. Seynaeve, D.W. Rea, J. Vannetzel, R. Paridaens, C. Markopoulos, Y. Hozumi, H. Putter, S.E. JonesVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70047-1
File:
PDF, 46 KB
english, 2010